×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
Yahoo Finance
Dosing of all patients in the trial has been successfully completed Final results are expected to be available in late Q2 2024 SAN DIEGO,...
1 day ago
Attorney General Bonta Announces Settlement with San Diego Company Over the Marketing of Its Genetic Testing ...
State of California - Department of Justice (.gov)
OAKLAND — California Attorney General Rob Bonta today announced a settlement with biotechnology company Biora Therapeutics, Inc.,...
7 months ago
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform ...
GlobeNewswire
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. ... BT-600 is being developed for the potential treatment of patients with...
4 weeks ago
Biora Therapeutics Shares Drop 26% After Pricing of Direct Offering
MarketWatch
By Chris Wack Biora Therapeutics shares were down after the company entered into definitive agreements for the purchase and sale of 5.5...
1 month ago
FDA clears IND for Biora Therapeutics's ulcerative colitis drug
Pharmaceutical Technology
The US Food and Drug Administration (FDA) cleared Biora Therapeutics's investigational new drug (IND) application for its ulcerative colitis (UC)...
5 months ago
Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Yahoo Finance
SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic...
1 month ago
Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
Biora-tm_rgb.jpg · Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules. April...
1 month ago
Biora Therapeutics Full Year 2023 Earnings: Beats Expectations
Yahoo Finance
Biora Therapeutics ( NASDAQ:BIOR ) Full Year 2023 Results Key Financial Results Net loss: US$124.3m (loss widened by...
1 month ago
Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
Biora Therapeutics is reimagining therapeutic delivery. By creating innovative smart pills designed for targeted drug delivery to the GI tract,...
1 month ago
Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset
Yahoo Finance
Monetization of legacy asset brings in $3 million in nondilutive capital Convertible notes exchange brings in another $2.8 million in new...
1 month ago